New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
June 25, 2014
10:59 EDTSWHC, PIR, VRTX, JBL, BBRY, SBGI, OHRP, RHT, MTOR, ARWROptions with decreasing implied volatility
Options with decreasing implied volatility: OHRP VRTX ARWR SBGI PIR MTOR BBRY SWHC RHT JBL
News For OHRP;VRTX;ARWR;SBGI;PIR;MTOR;BBRY;SWHC;RHT;JBL From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
1 | 2 | 3 | 4 | 5 | all recent news | >>
December 15, 2014
07:36 EDTBBRYBlackBerry December volatility elevated into Q3 and outlook
Subscribe for More Information
07:33 EDTARWRArrowhead submits IND for ARC-520 to begin Phase 2b studies
Arrowhead Research announced that it submitted an Investigational New Drug application to the U.S. Food and Drug Administration for ARC-520, itís drug candidate for the treatment of chronic hepatitis B virus infection. Arrowhead plans to submit additional clinical trial authorization applications with regulatory authorities in various jurisdictions in Europe and Asia. Pending national regulatory review and approval, Arrowhead intends to initiate two Phase 2b, multicenter, randomized, double-blind, placebo-controlled, multi-dose studies to determine the depth of hepatitis B surface antigen reduction following ARC-520 injection in combination with entecavir or tenofovir in patients with chronic immune active HBV infection. The Heparc-2002 study is planned to include patients who are negative for hepatitis B e-antigen at screening and the Heparc-2003 study is planned to include patients who are positive for HBeAg at screening. The primary objective is to evaluate the depth of HBsAg decline in response to multiple doses of ARC-520 compared to placebo in patients with chronic HBV infection as a measure of drug activity. Secondary objectives are to assess measures of safety and tolerability and to evaluate multi-dose pharmacokinetics of ARC-520 in patients with chronic HBV infection when co-administered with a fixed dose of entecavir or tenofovir, in addition to other exploratory safety and pharmacodynamic objectives.
December 12, 2014
10:28 EDTRHTRed Hat December volatility elevated into Q3 and outlook
Subscribe for More Information
10:01 EDTRHTOn The Fly: Analyst Initiation Summary
Subscribe for More Information
08:45 EDTPIRPier 1 Imports volatility elevated into Q3 and outlook
Subscribe for More Information
08:01 EDTVRTXPiper predicts two large-cap biotechs could be acquired in 2015
Subscribe for More Information
07:41 EDTJBLJabil Circuit volatility elevated into Q1 and outlook
Subscribe for More Information
06:35 EDTRHTRed Hat resumed with an Overweight at Piper Jaffray
Subscribe for More Information
December 11, 2014
13:19 EDTBBRYMicrosoft dropped by Ford for in-car sync system, Re/code reports
Ford's (F) Sync 3 in-car entertainment and mapping system will use a version of BlackBerry's (BBRY) QNX operating system, replacing Microsoft (MSFT) technology that had been used in the prior two versions, Re/code reports. The QNX-powered system adds more features, including a capacitive touch screen and the ability to get software updates over Wi-Fi. Ford said in a statement that its "hardware and software decisions were based on identifying the technology that would best meet the expectations for performance by our customers." Reference Link
13:09 EDTARWRArrowhead mentioned positively by Agora Financial
Agora Financial believes investors can "double [their] money ó virtually overnight." and have a "realistic chance" to make "up to 10 times [their] money" by investing in Arrowhead Research, according to a new research report from the firm. Arrowhead shares are up nearly 10% to $5.98 in afternoon trading. Reference Link
12:34 EDTPIRRestoration Hardware hits 52-week high after beating Q3 estimates
Subscribe for More Information
10:24 EDTSWHCOptions with decreasing implied volatility
Subscribe for More Information
09:59 EDTBBRYBlackBerry December volatility increases into Q3 and outlook
Subscribe for More Information
07:28 EDTVRTXCBI to hold a summit
2nd Specialty Data Optimization Summit is being held in Philadelphia on December 11.
December 10, 2014
10:20 EDTSWHCOptions with decreasing implied volatility
Subscribe for More Information
December 9, 2014
08:50 EDTBBRYBlackBerry CEO says China entry won't be rushed, won't include takeover
BlackBerry (BBRY) Executive Chairman and CEO John Chen, in a post to his LinkedIn account entitled "Don't Believe The Hype," stated that he has recently Iíve been advised to capitalize on Kim Kardashianís pronouncements that BlackBerry phones are her ďheart and soul,Ē or talk up plans to enter the China market, "however preliminary they are today." Chen said BlackBerry's focus right now is on extending its security foundation with new solutions for the enterprise and that it "cannot and will not" chase sensationalism. "As for China, rest assured that we are developing a well-thought out plan that will take into account many factors, including timing and our long-term strategy. It wonít be rushed because itís exciting or turned away from because of security concerns. And it wonít include a takeover," Chen wrote in his post. Reference Link
December 8, 2014
10:20 EDTSWHCOptions with decreasing implied volatility
Subscribe for More Information
10:00 EDTRHTOn The Fly: Analyst Downgrade Summary
Subscribe for More Information
08:14 EDTRHTRed Hat downgraded at Wells Fargo
As noted earlier, Wells Fargo downgraded Red Hat to Market Perform from Outperform. The firm downgraded the stock based on valuation. Target $64-$68.
05:54 EDTRHTRed Hat downgraded to Market Perform from Outperform at Wells Fargo
1 | 2 | 3 | 4 | 5 | all recent news | >>

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use